The post Sun Life (SLF) beats Q3 earnings estimates appeared on BitcoinEthereumNews.com. Sun Life (SLF) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +3.85%. A quarter ago, it was expected that this financial services company would post earnings of $1.29 per share when it actually produced earnings of $1.29, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Sun Life, which belongs to the Zacks Insurance – Life Insurance industry, posted revenues of $6.48 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.06%. This compares to year-ago revenues of $6.29 billion. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call. Sun Life shares have added about 3.4% since the beginning of the year versus the S&P 500’s gain of 15.1%. What’s next for Sun Life? While Sun Life has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an… The post Sun Life (SLF) beats Q3 earnings estimates appeared on BitcoinEthereumNews.com. Sun Life (SLF) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +3.85%. A quarter ago, it was expected that this financial services company would post earnings of $1.29 per share when it actually produced earnings of $1.29, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Sun Life, which belongs to the Zacks Insurance – Life Insurance industry, posted revenues of $6.48 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.06%. This compares to year-ago revenues of $6.29 billion. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call. Sun Life shares have added about 3.4% since the beginning of the year versus the S&P 500’s gain of 15.1%. What’s next for Sun Life? While Sun Life has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an…

Sun Life (SLF) beats Q3 earnings estimates

For feedback or concerns regarding this content, please contact us at [email protected]

Sun Life (SLF) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.29 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.85%. A quarter ago, it was expected that this financial services company would post earnings of $1.29 per share when it actually produced earnings of $1.29, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Sun Life, which belongs to the Zacks Insurance – Life Insurance industry, posted revenues of $6.48 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.06%. This compares to year-ago revenues of $6.29 billion. The company has topped consensus revenue estimates just once over the last four quarters.

The sustainability of the stock’s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management’s commentary on the earnings call.

Sun Life shares have added about 3.4% since the beginning of the year versus the S&P 500’s gain of 15.1%.

What’s next for Sun Life?

While Sun Life has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company’s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Sun Life was mixed. While the magnitude and direction of estimate revisions could change following the company’s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.36 on $6.84 billion in revenues for the coming quarter and $5.27 on $27.79 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Insurance – Life Insurance is currently in the top 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Abacus Life, Inc. (ABL), another stock in the same industry, has yet to report results for the quarter ended September 2025. The results are expected to be released on November 6.

This company is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents a year-over-year change of -10%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Abacus Life, Inc.’s revenues are expected to be $47.42 million, up 68.5% from the year-ago quarter.


Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Click to get this free report

Source: https://www.fxstreet.com/news/sun-life-slf-beats-q3-earnings-estimates-202511060910

Market Opportunity
SUN Logo
SUN Price(SUN)
$0.016814
$0.016814$0.016814
+1.11%
USD
SUN (SUN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Share
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26